“…Weight reduction surgery has shown improvement in outcomes including all-cause mortality and diabetes remission, which have remained for over a decade after the initial surgery [ 53 , 54 ]; however, only a small percentage of eligible patients undergo WRS, including only 1 in 50 eligible patients with T2DM [ 37 ]. Previously cited barriers to weight management treatment have included financial access and cost and a lack of clinical resources, provider and patient knowledge of evidence-based treatment guidelines, recognition of obesity as a chronic disease, and provider confidence in long-term benefit and safety [ 22 , 25 , [55] , [56] , [57] , [58] , [59] , [60] ]; however, effective solutions to address these barriers remain limited [ 61 ].…”